School of Pharmacy, Sungkyunkwan University , Suwon 16419, Republic of Korea.
Biocenter, Gyeonggido Business & Science Accelerator (GBSA) , Suwon 16229, Republic of Korea.
J Org Chem. 2017 Nov 3;82(21):11566-11572. doi: 10.1021/acs.joc.7b02212.
The first total synthesis and biological evaluation of penchinone A and its structural analogues are described. The key steps for the preparation of penchinone A derivatives involve the oxime-directed palladium(II)-catalyzed oxidative acylation, Claisen rearrangement, and base-mediated olefin migration. This transformation efficiently provides a range of allyl-substituted biaryl ketones with site-selectivity and functional group compatibility. In addition, all synthetic compounds were screened for anti-inflammatory activity against nitric oxide (NO), tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6) with lipopolysaccharide (LPS)-induced RAW264.7 cells. Generally, a range of penchinone A derivatives potently inhibited NO, TNF-α, and IL-6 productions, compared to dexamethasone as a positive control. Notably, penchinone A (8g) and its derivatives (8e and 8f) were found to exhibit anti-inflammatory activity stronger than that of dexamethasone.
首次对 penchinone A 及其结构类似物进行了全合成及生物评价。 penchinone A 衍生物的制备关键步骤涉及肟导向的钯 (II)-催化氧化酰化、Claisen 重排和碱介导的烯烃迁移。该转化高效提供了一系列具有位点选择性和官能团兼容性的烯丙基取代联芳基酮。此外,所有合成化合物均针对一氧化氮 (NO)、肿瘤坏死因子-α (TNF-α) 和白细胞介素-6 (IL-6) 进行了抗炎活性筛选,采用脂多糖 (LPS) 诱导的 RAW264.7 细胞。通常,与地塞米松作为阳性对照相比,一系列 penchinone A 衍生物能强烈抑制 NO、TNF-α 和 IL-6 的产生。值得注意的是,penchinone A(8g)及其衍生物(8e 和 8f)表现出的抗炎活性强于地塞米松。